Nasus Pharma
NSRX
Nasus Pharma (NSRX) news
Recent news
Nasus Pharma announces transition of chief financial officer
AInvest Wire · Aug 19, 2026Nasus Pharma reports first half 2026 financial results and provides business update
Nasus Pharma (NYSEAMK:NSRX) has provided an update on its business and operations for the first half of 2026, highlighting key developments in its pipeline of intranasal drug delivery products. The company, which focuses on clinical-stage biopharmaceutical innovations, reported preclinical…
AInvest Wire · Aug 17, 2026Nasus Pharma - Brendan P. O'Grady succeeds Dan Teleman as CEO effective July 27, 2026
AInvest Wire · Jul 28, 2026ImportantMerz on pharma: expect US to stand by trade commitments
AInvest Wire · Jun 19, 2026ImportantPharma Mar shares decline 16% on trial results
AInvest Wire · Jun 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.